1 Vivek Kumar, MD, is an assistant professor in the department of nephrology at the Postgraduate Institute of Medical Education and Research in Chandgarh, India. Vijay Singh, MSc, PhD, is associated with the department of nephrology at the Postgraduate Institute of Medical Education and Research in Chandgarh, India. Vivekanand Jha, MBBS, MD, DM, PhD, is executive director of the George Institute for Global Health, India; professor of nephrology, University of Oxford; conjoint professor of medicine, University of New South Wales, Sydney; and president of the International Society of Nephrology.
Humans face an unprecedented situation today. Human coronavirus disease 19 (COVID-19) has caught everyone, regardless of borders and competence of existing healthcare infrastructures, completely unaware.
The way the disease has spread across the world over 4 months aptly reflects the meaning of “viral” as it is used in social media, where the term frequently describes something that garners immense worldwide publicity within a very short time. The sudden temporal clustering of numerous cases of unexplained rapidly progressive pneumonia leading to respiratory failure baffled clinicians in Wuhan, China, in December 2019. As could be expected, suspicion of some new affliction grew